Q3 2022 Holdings
Filed 2022-11-14 | 76 holdings | $419.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $139.0M | 3,123,300 | 33.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $98.0M | 5,991,479 | 23.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $48.5M | 4,488,200 | 11.5% |
| Alector Inc(ALEC) | COM | 014442107 | $38.4M | 4,056,548 | 9.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $35.2M | 6,184,861 | 8.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $26.1M | 1,330,263 | 6.2% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $14.7M | 1,143,218 | 3.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $7.9M | 415,322 | 1.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $6.2M | 17,527 | 1.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.8M | 27,208 | 0.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $702.4K | 11,584,280 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $354.0K | 5,183,431 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $331.6K | 2,999,453 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $191.9K | 7,521,024 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $137.2K | 5,282,516 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $136.3K | 3,197,500 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $111.8K | 3,951,566 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $98.7K | 3,460,208 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $93.1K | 4,163,824 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $90.7K | 6,638,371 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $70.9K | 1,015,572 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $69.4K | 2,030,252 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $49.8K | 4,160,887 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $47.3K | 2,899,285 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $42.1K | 2,519,268 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $39.1K | 285,793 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $35.5K | 1,801,847 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $34.4K | 3,493,194 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $34.1K | 2,341,313 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $31.1K | 13,896,543 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $28.1K | 4,753,907 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $19.2K | 1,421,319 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $17.3K | 796,093 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $15.2K | 4,201,414 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $14.0K | 400,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $13.6K | 690,000 | 0.0% |
| Akouos Inc | COM | 00973J101 | $13.4K | 1,975,984 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $13.0K | 3,236,352 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $11.3K | 6,117,400 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $10.9K | 3,418,068 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $9.4K | 2,650,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $7.1K | 541,108 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $6.7K | 5,000,000 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $6.5K | 5,035,971 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $6.2K | 1,921,310 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $5.7K | 3,500,000 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $5.4K | 2,301,980 | 0.0% |
| Aveo Pharmaceuticals Inc(0HJQ) | COM NEW | 053588307 | $5.4K | 650,489 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $5.3K | 678,441 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $5.0K | 1,582,135 | 0.0% |